首页> 美国卫生研究院文献>Case Reports in Dermatology >Psoriasis Vitiligo and Biologic Therapy: Case Report and Narrative Review
【2h】

Psoriasis Vitiligo and Biologic Therapy: Case Report and Narrative Review

机译:牛皮癣白癜风和生物治疗:案例报告和叙事审查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Psoriasis and vitiligo are 2 multifactorial immune-mediated diseases, partially sharing pathogenetic underpinnings. Their coexistence in the same patient, although uncommon, is documented in the literature. Further, several cases of vitiligo induced by biological drugs in psoriatic patients are reported. However, improvements in psoriasis and pre-existing vitiligo after the introduction of biological therapy are also described. To date, anti-TNF-alpha is the most cited group of biological drugs that induce new-onset vitiligo or progression of pre-existence vitiligo in psoriatic patients. Even anti-IL-12/23 class would seem to induce vitiligo (as in our case) or even worse it. Anti-IL-17 drugs induce a progression of pre-existing vitiligo while, to date, no cases are reported in literature considering anti-IL-23 class.
机译:牛皮癣和白癜风是2个多因素免疫介导的疾病,部分分享致病内衬。他们在同一患者的共存虽然罕见,但在文献中记录了。此外,据报道了通过生物药物在银屑病患者中诱导的几种白癜风病例。然而,还描述了在引入生物疗法后的牛皮癣和预先存在的白癜风。迄今为止,抗TNF-α是最引用的生物药物组,其诱导新手患者的新出售白癜风或进展的白癜风患者。甚至反IL-12/23课似乎诱导白癜风(如我们的案例)甚至更糟糕的是。抗IL-17药物诱导预先存在的白癜风进展,而迄今为止,在考虑反IL-23课程的文献中没有报告任何病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号